Robert Van Waterschoot

Title: The Innovative Contributions of Robert Van Waterschoot

Introduction

Robert Van Waterschoot is a notable inventor based in Riehen, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target the dopamine D3 receptor. With a total of three patents to his name, his work has the potential to impact the treatment of various disorders.

Latest Patents

One of his latest patents focuses on acylaminocycloalkyl compounds that are suitable for treating disorders that respond to modulation of the dopamine D3 receptor. This invention relates to novel compounds, specifically those described in formula I, along with their salts and N-oxides. These compounds exhibit valuable therapeutic properties, making them particularly relevant for treating diseases associated with the dopamine D3 receptor.

Career Highlights

Throughout his career, Robert has worked with prominent companies in the pharmaceutical industry, including AbbVie Inc. and AbbVie Deutschland GmbH & Co. KG. His experience in these organizations has allowed him to refine his expertise and contribute to innovative solutions in drug development.

Collaborations

Robert has collaborated with several professionals in his field, including Andreas Haupt and Jürgen Dinges. These partnerships have likely enhanced his research and development efforts, leading to the successful creation of his patented compounds.

Conclusion

Robert Van Waterschoot's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the area of dopamine D3 receptor modulation, hold promise for advancing therapeutic options for various disorders.